Journal of the American Academy of Dermatology
Volume 60, Issue 1 , Pages 120-124, January 2009

Treatment of intertriginous psoriasis: From the Medical Board of the National Psoriasis Foundation

  • Robert E. Kalb, MD

      Affiliations

    • Department of Dermatology, State University of New York School of Medicine and Biomedical Sciences, Buffalo, New York
  • ,
  • Jerry Bagel, MD

      Affiliations

    • College of Physicians and Surgeons of Columbia University, New York, New York
    • Psoriasis Treatment Center of Central New Jersey, East Windsor, New Jersey
  • ,
  • Neil J. Korman, MD, PhD

      Affiliations

    • Murdough Family Center for Psoriasis, Case Western Reserve University/University Hospital of Cleveland, Cleveland, Ohio
  • ,
  • Mark G. Lebwohl, MD

      Affiliations

    • Department of Dermatology, Mount Sinai School of Medicine, New York, New York
  • ,
  • Melodie Young, MSN, RN, ANP

      Affiliations

    • Modern Dermatology, Dallas, Texas
  • ,
  • Elizabeth J. Horn, PhD, MBI

      Affiliations

    • National Psoriasis Foundation, Portland, Oregon
  • ,
  • Abby S. Van Voorhees, MD

      Affiliations

    • Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania
    • Corresponding Author InformationCorrespondence to: Abby S. Van Voorhees, MD, Hospital of the University of Pennsylvania, 2 Rhoads 3400 Spruce St, Philadelphia, PA 19104.
  • ,
  • National Psoriasis Foundation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by the National Psoriasis Foundation.

 Disclosure: Dr Kalb is a consultant and/or investigator for Amgen, Abbott, Astellas, Centocor, Genentech, and Warner-Chilcott and his practice provides phototherapy services. Dr Bagel is a clinical investigator for Centocor and a speaker for Amgen, Genentech, Abbott, Astellas, and Novartis, and his practice provides phototherapy services. Dr Korman is an investigator for or receives grant support from Abbott Laboratories, Amgen, Astellas, Biogen Idec, Centocor, Genentech, Genmab, Novartis, Peplin, and Seattle Genetics. He is also a speaker or consultant for Abbott Laboratories, Amgen, Genentech, Genmab, Novartis, and Peplin, and his practice provides phototherapy services. Dr Lebwohl is an investigator for Abbott Laboratories, Amgen, Astellas, Centocor, Connetics, Galderma, Genentech, 3M, Novartis, and Warner Chilcott. He is also a consultant for Abbott, Amgen, Astellas, BristolMyersSquibb, Centocor, Connetics, Galderma, Genentech, 3M, Novartis, Pfizer, and Warner Chilcott and speaker for Abbott, Amgen, Astellas, Centocor, Chester Valley, Connetics, Galderma, Genentech, 3M, Novartis, PharmaDerm, and Warner Chilcott, and his practice provides phototherapy services. Ms Young is a speaker for Abbott, Amgen, Connetics, and Genentech, an advisory board member for Abbott, Amgen, and Genentech, and her clinic provides phototherapy services. Dr Horn was an employee of the National Psoriasis Foundation. The National Psoriasis Foundation receives unrestricted funding from Abbott Immunology, Amgen and Wyeth, Astellas Pharma Inc, Barrier Therapeuics, Beiersdorf, Centocor, Daavlin, Galderma Laboratories, Genentech, National Biologic Corporation, Neutrogena, Photomedex, Stiefel Laboratories, and Warner Chilcott. Dr Van Voorhees has received grant support from Amgen, Astellas, and Warner Chilcott. She has been a consultant, advisory board member, or speaker for Abbott, Amgen, Centocor, Connetics, Genentech, and Warner Chilcott and a drug safety monitoring board member for Synta. She is a major stockholder in Merck. She provides phototherapy services as well.

 Reprints not available from the authors.

PII: S0190-9622(08)00807-4

doi:10.1016/j.jaad.2008.06.041

Journal of the American Academy of Dermatology
Volume 60, Issue 1 , Pages 120-124, January 2009